Neocis, Inc., the leader and pioneer in robot-assisted dental implant surgery, announced today that they have received 510(k) clearance from the US Food and Drug Administration (FDA) for a new Yomi® edentulous indication. The clearance allows for a new splint attachment which broadens Yomi’s application to include full arch implant cases as well as partially edentulous cases. The American College of Prosthodontists estimates that over 36 million Americans are missing all their teeth. The new Yomi edentulous splint will enable doctors to use Yomi’s technology to reach more of this population.
“I am delighted today to report that we have received 510(k) clearance for Yomi to assist with full arch implant surgeries. With this clearance, Yomi doctors will be able to leverage robotic technology to treat more patients and restore more smiles,” said Alon Mozes, PhD, Chief Executive Officer of Neocis.
Read more: https://www.aegisdentalnetwork.com/id/news/2020/07/29/neocis-announces-new-fda510k–clearance-enabling-the-yomi-dDental-robotic-system-to-assist-with-full-arch%20Implant%20Treatment